Clarke, Earl <br/><br/>
Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist.  [electronic resource] 

 -  Bioorganic & medicinal chemistry  02 2018 
 - 798-814 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-3391 
<br/><br/><label>Standard No.: </label>10.1016/j.bmc.2017.12.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aminobenzoates--chemistry<br/>Animals<br/>Benzoates--chemistry<br/>COS Cells<br/>Cell Survival--drug effects<br/>Chlorocebus aethiops<br/>Drug Design<br/>Half-Life<br/>Hep G2 Cells<br/>Humans<br/>Mice<br/>Microsomes, Liver--metabolism<br/>Rats<br/>Receptors, Retinoic Acid--agonists<br/>Retinoic Acid Receptor alpha--agonists<br/>Structure-Activity Relationship<br/>Tetrahydronaphthalenes--chemistry<br/>Retinoic Acid Receptor gamma